• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

An Epithelial Integrin Regulates the Amplitude of Protective Lung Interferon Responses against Multiple Respiratory Pathogens

tetano

Editor, Senior Moderator
PLoS Pathog. 2016 Aug 9;12(8):e1005804. doi: 10.1371/journal.ppat.1005804. eCollection 2016.
[h=1]An Epithelial Integrin Regulates the Amplitude of Protective Lung Interferon Responses against Multiple Respiratory Pathogens.[/h] Meliopoulos VA[SUP]1[/SUP], Van de Velde LA[SUP]1,[/SUP][SUP]2[/SUP], Van de Velde NC[SUP]1,[/SUP][SUP]2[/SUP], Karlsson EA[SUP]1[/SUP], Neale G[SUP]3[/SUP], Vogel P[SUP]4[/SUP], Guy C[SUP]2[/SUP], Sharma S[SUP]2[/SUP], Duan S[SUP]2[/SUP], Surman SL[SUP]1[/SUP], Jones BG[SUP]1[/SUP], Johnson MD[SUP]1[/SUP], Bosio C[SUP]5[/SUP], Jolly L[SUP]6[/SUP], Jenkins RG[SUP]6[/SUP], Hurwitz JL[SUP]1[/SUP], Rosch JW[SUP]1[/SUP], Sheppard D[SUP]7[/SUP], Thomas PG[SUP]2[/SUP], Murray PJ[SUP]1,[/SUP][SUP]2[/SUP], Schultz-Cherry S[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The healthy lung maintains a steady state of immune readiness to rapidly respond to injury from invaders. Integrins are important for setting the parameters of this resting state, particularly the epithelial-restricted αVβ6 integrin, which is upregulated during injury. Once expressed, αVβ6 moderates acute lung injury (ALI) through as yet undefined molecular mechanisms. We show that the upregulation of β6 during influenza infection is involved in disease pathogenesis. β6-deficient mice (β6 KO) have increased survival during influenza infection likely due to the limited viral spread into the alveolar spaces leading to reduced ALI. Although the β6 KO have morphologically normal lungs, they harbor constitutively activated lung CD11b+ alveolar macrophages (AM) and elevated type I IFN signaling activity, which we traced to the loss of β6-activated transforming growth factor-β (TGF-β). Administration of exogenous TGF-β to β6 KO mice leads to reduced numbers of CD11b+ AMs, decreased type I IFN signaling activity and loss of the protective phenotype during influenza infection. Protection extended to other respiratory pathogens such as Sendai virus and bacterial pneumonia. Our studies demonstrate that the loss of one epithelial protein, αVβ6 integrin, can alter the lung microenvironment during both homeostasis and respiratory infection leading to reduced lung injury and improved survival.


PMID: 27505057 DOI: 10.1371/journal.ppat.1005804
[PubMed - as supplied by publisher]
 
Back
Top Bottom